Liaoning Chengda Biotechnology Co.,Ltd. (SHA:688739)
China flag China · Delayed Price · Currency is CNY
24.38
-0.41 (-1.65%)
Apr 17, 2026, 4:00 PM EDT

SHA:688739 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,3901,6761,7501,8152,088
Revenue Growth (YoY)
-17.06%-4.22%-3.58%-13.08%4.63%
Cost of Revenue
286.82319.24342.56243.28220.37
Gross Profit
1,1031,3571,4081,5721,868
Selling, General & Admin
609.38659.02648.29588.41603.58
Research & Development
294.04281.94219.96210.89236.82
Other Operating Expenses
3.0722.6321.8622.120.82
Operating Expenses
906.49972.25902.89836.49877.65
Operating Income
196.98384.75504.66735.23990.02
Interest Expense
--1.58-1.42-1.32-1.54
Interest & Investment Income
15.9370.596.81128.345.81
Currency Exchange Gain (Loss)
-0.842.472.5-0.48
Other Non Operating Income (Expenses)
25.61-0.28-0.82-0.47-0.42
EBT Excluding Unusual Items
238.52454.22601.71864.251,033
Gain (Loss) on Sale of Investments
63.17-75.57-45.29-43.63-25.53
Gain (Loss) on Sale of Assets
-0-1.721.61-0.79-0.69
Asset Writedown
-132.09----
Other Unusual Items
-26.0818.3618.2523.81
Pretax Income
169.6403.02576.38838.071,031
Income Tax Expense
37.8160.2110.46124.05138.49
Net Income
131.79342.82465.92714.02892.49
Net Income to Common
131.79342.82465.92714.02892.49
Net Income Growth
-61.56%-26.42%-34.75%-20.00%-2.80%
Shares Outstanding (Basic)
412413416418381
Shares Outstanding (Diluted)
412413416418381
Shares Change (YoY)
-0.29%-0.71%-0.37%9.48%1.77%
EPS (Basic)
0.320.831.121.712.34
EPS (Diluted)
0.320.831.121.712.34
EPS Growth
-61.45%-25.89%-34.50%-26.92%-4.49%
Free Cash Flow
32.78138.48125.0234.89-1.97
Free Cash Flow Per Share
0.080.340.300.08-0.01
Dividend Per Share
-0.8000.8001.0001.000
Dividend Growth
---20.00%--
Gross Margin
79.37%80.95%80.43%86.60%89.45%
Operating Margin
14.17%22.95%28.84%40.51%47.41%
Profit Margin
9.48%20.45%26.62%39.34%42.74%
Free Cash Flow Margin
2.36%8.26%7.14%1.92%-0.09%
EBITDA
370.6549.77624.89851.421,101
EBITDA Margin
26.66%32.80%35.71%46.91%52.73%
D&A For EBITDA
173.62165.02120.24116.19111.07
EBIT
196.98384.75504.66735.23990.02
EBIT Margin
14.17%22.95%28.84%40.51%47.41%
Effective Tax Rate
22.30%14.94%19.16%14.80%13.43%
Revenue as Reported
-1,6761,7501,8152,088
Source: S&P Global Market Intelligence. Standard template. Financial Sources.